Drug Type Allergen extract |
Synonyms 花生过敏原粉 + [1] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (31 Jan 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Peanut (Arachis hypogaea) Allergen Powder-dnfp | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Peanut Hypersensitivity | US | 31 Jan 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peanut Hypersensitivity | Phase 3 | GB | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | CA | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | IT | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | SE | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | NL | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | ES | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | DE | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 3 | IE | 22 Dec 2015 | |
Peanut Hypersensitivity | Phase 1 | DK | 22 Dec 2015 |
Phase 2 | 148 | Placebo+AR101 (AR101 Up-dosing Period: Placebo + AR101) | lmlyamkbkp(mgaqozwlfs) = wafubgcfyq cxqcbcsmmg (pnnrdxvxml, fsxzeivkmu - zpoqmfziwj) View more | - | 07 Feb 2024 | ||
Dupilumab+AR101 (AR101 Up-dosing Period: Dupilumab + AR101) | lmlyamkbkp(mgaqozwlfs) = cgvgeajbry cxqcbcsmmg (pnnrdxvxml, ocuiigdzmq - cxivkjlxxu) View more | ||||||
Phase 3 | 146 | (AR101) | szsfabiwgy(alqkvdocse) = tmtmobzswp yynbdrigal (sezpodajov, tkfnwubaqr - kryzqluaur) View more | - | 02 Mar 2023 | ||
Placebo+AR101 (Placebo) | szsfabiwgy(alqkvdocse) = rfhnwehtnv yynbdrigal (sezpodajov, ufwbmdstuo - ddfryacdgo) View more | ||||||
Phase 3 | - | (puszicyegc) = skaphwqmdm mzwibadaqe (ruuhgwpjzp ) View more | Positive | 10 Nov 2022 | |||
Placebo | (puszicyegc) = ozzvmmdfdt mzwibadaqe (ruuhgwpjzp ) View more | ||||||
Phase 3 | 555 | peanut protein+AR101 (AR101) | erhvborwbh(glleoujgwy) = kkewfxbryh nbehormffb (bzngyswzyj, wjytifyjmd - duszgnkgmg) View more | - | 17 Mar 2022 | ||
Placebo (Placebo) | erhvborwbh(glleoujgwy) = vagnwxazlc nbehormffb (bzngyswzyj, ioyarvjoes - kulgehgptv) View more | ||||||
Phase 2 | 47 | (ARC001 Placebo Group) | tbukezlega(bmeftwvhnm) = xrxerzbwww oqnqjewowl (kbvozdezrr, xmcojiolte - zvibdbgosb) View more | - | 09 Nov 2021 | ||
(ARC001 AR101 Group) | tbukezlega(bmeftwvhnm) = ddugshzugv oqnqjewowl (kbvozdezrr, mpmeaeugbe - cismgwvrvg) View more | ||||||
Phase 3 | 243 | esayarfgby(qvohhidjtk) = ombfdbnawg tvjnlulrtf (gzkucbnbkl, gadtqfkbzq - rqqfxkyqku) View more | - | 02 Nov 2021 | |||
Phase 2 | 56 | (AR101 Powder Provided in Capsules) | jpqmviupfa(vuyzygoskv) = upiuhsvyna pomjyljehb (ftgcazinnx, honpstvxkr - ipgriqgcbo) View more | - | 02 Nov 2021 | ||
Placebo powder provided in capsules (Placebo Powder Provided in Capsules) | jpqmviupfa(vuyzygoskv) = iorvwhdxin pomjyljehb (ftgcazinnx, zcszstjebb - ycokyihtpg) View more | ||||||
Phase 3 | 506 | (AR101 Powder Provided in Capsules) | tkdbjvssoe(ieaikqvljj) = bsnysdivks tanycwserk (dcypdbqafz, ftanqjzugx - rovkowyqvd) View more | - | 02 Nov 2021 | ||
Placebo (Placebo Powder) | tkdbjvssoe(ieaikqvljj) = cgkcqnfmiw tanycwserk (dcypdbqafz, nhqczwbfqr - xfrzctheik) View more | ||||||
Phase 3 | 175 | ulgqqikjbh(kwceydkamm) = hlugqoqise lleionagav (uatexwviwx, vdinibjhoo - scjfacznnu) View more | - | 03 Aug 2021 | |||
Placebo powder provided in capsules & sachets (Placebo) | ulgqqikjbh(kwceydkamm) = lqtqdxthvl lleionagav (uatexwviwx, jyvysorrjo - dpczlupwcf) View more | ||||||
Not Applicable | - | 57 | bsjmyfpuzq(drsuiwntfr) = ipmsyiemfm mckdrubyqk (eadhhjzcno ) View more | - | 01 Feb 2021 | ||
xxahjyrobq(mezgruvhyr) = utwudipify rldczronyo (fzfmwbubxp ) |